Alonso O - Search Results

1

Development and Evaluation of ^99mTc Tricarbonyl Complexes Derived from Flutamide with Affinity for Androgen Receptor.

Cardoso ME, Decuadra P, Zeni M, Delfino A, Tejería E, Coppe F, Mesa JM, Daher G, Giglio J, Carrau G, Gamenara D, Alonso O, Terán M, Rey A. Cardoso ME, et al. Among authors: alonso o. Molecules. 2023 Jan 13;28(2):820. doi: 10.3390/molecules28020820. Molecules. 2023. PMID: 36677878 Free PMC article.

2

99mTc-HYNIC octreotide in neuroblastoma.

Gambini JP, López Lerena JJ, Quagliata A, Hermida JC, Heuguerot C, Alonso O. Gambini JP, et al. Among authors: alonso o. Ann Nucl Med. 2008 Nov;22(9):817-9. doi: 10.1007/s12149-008-0201-9. Epub 2008 Nov 28. Ann Nucl Med. 2008. PMID: 19039561

3

Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model.

Gambini JP, Cabral P, Alonso O, Savio E, Figueroa SD, Zhang X, Ma L, Deutscher SL, Quinn TP. Gambini JP, et al. Among authors: alonso o. Nucl Med Biol. 2011 Feb;38(2):255-60. doi: 10.1016/j.nucmedbio.2010.08.002. Epub 2010 Oct 27. Nucl Med Biol. 2011. PMID: 21315281

4

Preparation and primary bioevaluation of 99mTc-labeled-1-thio-β-D-glucose as melanoma targeting agent.

Castelli R, Fernández M, Porcal W, Gambini JP, Alonso O, Chabalgoity A, Moreno M, Cabral P. Castelli R, et al. Among authors: alonso o. Curr Radiopharm. 2011 Oct;4(4):355-60. doi: 10.2174/1874471011104040355. Curr Radiopharm. 2011. PMID: 22202158

5

Development of 99mTc(CO)₃-dendrimer-FITC for cancer imaging.

Tassano MR, Audicio PF, Gambini JP, Fernandez M, Damian JP, Moreno M, Chabalgoity JA, Alonso O, Benech JC, Cabral P. Tassano MR, et al. Among authors: alonso o. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5598-601. doi: 10.1016/j.bmcl.2011.06.079. Epub 2011 Jun 30. Bioorg Med Chem Lett. 2011. PMID: 21778055

6

[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model.

Camacho X, García MF, Calzada V, Fernández M, Chabalgoity JA, Moreno M, Barbosa de Aguiar R, Alonso O, Gambini JP, Chammas R, Cabral P. Camacho X, et al. Among authors: alonso o. Oncology. 2013;84(4):200-9. doi: 10.1159/000338961. Epub 2013 Jan 15. Oncology. 2013. PMID: 23328435

7

Synthesis of 99mTc-nimotuzumab with tricarbonyl ion: in vitro and in vivo studies.

Garcia MF, Camacho X, Calzada V, Fernandez M, Porcal W, Alonso O, Gambini JP, Cabral P. Garcia MF, et al. Among authors: alonso o. Curr Radiopharm. 2012 Jan;5(1):59-64. doi: 10.2174/1874471011205010059. Curr Radiopharm. 2012. PMID: 22074480

8

[Value of radioguided surgery with dobutamine 99mTc-MIBI in persistent secondary hyperparathyroidism].

Quagliata A, López JJ, Juri C, Alonso O. Quagliata A, et al. Among authors: alonso o. Rev Esp Med Nucl. 2006 Nov-Dec;25(6):387-90. doi: 10.1157/13095173. Rev Esp Med Nucl. 2006. PMID: 17173788 Spanish.

9

Evaluation of patients with head and neck cancer by means of 99mTc-glucarate.

Gambini JP, Nuñez M, Cabral P, Lafferranderie M, Noble J, Corchs E, D'Albora R, Savio E, Delgado L, Alonso O. Gambini JP, et al. Among authors: alonso o. J Nucl Med Technol. 2009 Dec;37(4):229-32. doi: 10.2967/jnmt.109.062927. J Nucl Med Technol. 2009. PMID: 19949020 Free article. Clinical Trial.

10

Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging Agents.

Calzada V, García MF, Alonso-Martínez LM, Camachoc X, Goicochea E, Fernández M, Castillo AX, Díaz-Miqueli A, Iznaga-Escobar N, Montaña RL, Alonso O, Gambini JP, Cabral P. Calzada V, et al. Among authors: alonso o, alonso martinez lm. Anticancer Agents Med Chem. 2016;16(9):1184-9. doi: 10.2174/1871520616666160310143828. Anticancer Agents Med Chem. 2016. PMID: 26961312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page